A rating of 30 puts Ionis Pharmaceuticals Inc (IONS) near the bottom of the Biotechnology industry according to InvestorsObserver. Ionis Pharmaceuticals Inc's score of 30 means it scores higher than 30% of stocks in the industry. Ionis Pharmaceuticals Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 27 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 38 would rank higher than 38 percent of all stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Ionis Pharmaceuticals Inc (IONS) stock is trading at $46.79 as of 1:16 PM on Monday, Oct 5, an increase of $1.13, or 2.49% from the previous closing price of $45.65. The stock has traded between $46.04 and $47.20 so far today. Volume today is 1,079,820 compared to average volume of 926,841.

Click Here to get the full Stock Score Report on Ionis Pharmaceuticals Inc (IONS) Stock.

Visit link:
Where Does Ionis Pharmaceuticals Inc (IONS) Stock Fall in the Biotechnology Field? - InvestorsObserver